days left

Virtual EASD 2021

57th Annual Meeting of the
European Association for the Study of Diabetes

27 September  - 1 October 2021

The EASD 2021 Final Programme is now online

online Flipbook or PDF for download

Instructions for Oral and Short Oral Presentations

Oral Presentations Short Oral Presentations

EFSD welcomes applications for the following programmes:

EFSD Anniversary Fund Programme
Application Deadline: 16 August 2021

EFSD and Lilly European Diabetes Research Programme
Application Deadline: 1 September 2021

Application Deadline: 2 November 2021

EFSD and EUDF Digitalisation in Diabetes Care Research Grant
Application Deadline: 15 November 2021

Hypoglycaemia in older people

Two of the most commonly cited global health challenges are ageing populations and the rising tide of diabetes, yet the two are rarely considered together. Find out more in the EASD e-Learning module with Prof. Brian Frier on hypoglycaemia in older people.


Be part of the EASD 2021 photo mosaic

Share your picture and leave a message - let the world know that you are an EASD 2021 supporter and invite your friends and colleagues to join us at EASD 2021.


(Note: The EASD 2021 photo mosaic is managed by Interplan and may include sponsored content)

Explore scientific content of EASD Annual Meetings!

All posters and presentation recordings from recent EASD Annual Meetings are available for free to all. Explore 1000's of webcasts showcasing up-to-date basic and clinical research which influences day-to-day diabetes care around the world. more

The European Foundation for the Study of Diabetes (EFSD) was created by EASD to provide funding in all areas of diabetes research across the entire European Region. The aims of EFSD are to encourage and support groundbreaking diabetes research and to promote the next generation of leading diabetes researchers. more

Impact Factor 2020: 10.1

Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. more